Biosimilars LatAm – Colombia 2025
Focused on fostering greater access to biosimilars in Colombia, this forum gathers decision-makers from the pharmaceutical industry, regulatory bodies, and associations to share success stories and actionable insights. With dynamic presentations, interactive panels, and networking opportunities, the event emphasizes the strategic importance of vaccines and plasma-derived products. Discussions will cover recent regulatory advancements, strategies for self-sufficiency, and collaborations with leading institutions to build local biotech capabilities.
Key Objectives:
– Analyze recent regulatory and strategic advancements positioning Colombia on the biosimilars map, identifying areas for investment and alliances.
– Examine the role of the industry in ensuring self-sufficiency in critical medicines, exploring government incentives and integration policies.
– Investigate training programs in advanced skills and technology transfer through partnerships with leading Latin American institutions.
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board
Vladimir Camacho Cuineme
Chief Executive Officer
Susana Zavala
Biologic Executive
Julieta Ramirez
Analytical Development Lead
Susana Millan
Medical Director
Dario Ramirez
Business Unit Manager – Specialized and Institutional Care
Sandra Bibiana Malungo
Access Manager
Aditya Vadrevu
Global Biopharma Technical Manager
Edwin Cruz
Manager of Process Consulting
Peter Gurske
Managing Director
Federman Nunez
President
Rocio Parra
Global Strategy Director
Sol Ruiz
Head of Biologics, Advanced Therapies, and Biotechnology
Carolina Wiesner Ceballos
General Director
Marcelo Holanda
Head of Latam
Tonatiuh Cortes Esquivel
Sr Strategic Project Manager
Miguel Angel Bustos
Lider Cluster Farmacéutico
Adriana Robayo
Executive Director
Claudia Vaca
Founder and Head
Program at a Glance
Advanced Local Regulation: Unlocking the Potential of Biosimilars
Examine recent updates to Colombia’s regulatory framework, focusing on accelerating approval timelines and aligning with international standards to enhance market access for biosimilars.
Strategies for the Consolidation of the Biosimilars Industry: Lessons Learned from biosimilars in Eurpe tos upport biosimilar’s development in the region
Evaluate key strategic initiatives to strengthen the Colombian biosimilars sector, ensuring long-term sustainability, competitiveness, and regional leadership.
Tailored Process and Facility Design for Biopharmaceutical Production
Tangential flow filtration solutions to meet the complex and novel biologic processes
Advancements in the Tangential flow filtration technology addresses the challenges of novel biologics in terms of membrane fouling and handling shear sensitive molecules. With tailored and optimised TFF steps, we can acheive the purification and separation, with a focus on quality and yield.
Redefining the Role of Industry in LATAM’s Health Autonomy
Analyze the industry’s role in securing Colombia’s self-sufficiency in essential medicines, focusing on government incentives, policy integration, and strategic partnerships.
Data Box: Strategic Opportunities for the Local Industry
Data Box: Data Access of PDPs for Innovation and Production of Biosimilars
Assess the role of Public-Private Development Partnerships (PDPs) in fostering innovation, improving data accessibility, and enhancing local biosimilar production capabilities.
Strengthening Capacities: Education and Technology Transfer
Examine advanced training programs and institutional collaborations that drive technology transfer and capacity building in the Latin American biosimilars sector.
Full Programme in the PDF Agenda
Download Agenda
Sponsors
Media Partners
Photo Gallery
Testimonials
-
”What you and your team are doing to advance the biosimilars industry is nothing short of inspiring. The dedication, vision, and passion that drive your work not only create a platform for meaningful discussions but also pave the way for real-world solutions that can positively impact countless lives around the globe. I deeply admire the effort and commitment you all bring to making this a space for innovation and collaboration.”
Srinivas Komala, Country Manager at MSN Labs, Brazil
-
”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”
Alison Bascou, Sr. Regulatory Director at BD, France
-
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."
Jaime Uribe, CEO At PROBIOMED
-
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”
Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
-
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”
Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
-
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”
Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico